EPS8 anticorps (AA 572-670)

N° du produit ABIN7151882

Détail du produit anti-EPS8 anticorps

Antigène: EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8))

Épitope: AA 572-670

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EPS8 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Epidermal growth factor receptor kinase substrate 8 protein (572-670AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:200-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur EPS8

Antigène: EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8))

Autre désignation: EPS8 (EPS8 Produits)

Synonymes: anticorps AW261790, anticorps MGC81285, anticorps MGC146320, anticorps zgc:56041, anticorps epidermal growth factor receptor pathway substrate 8, anticorps epidermal growth factor receptor pathway substrate 8 L homeolog, anticorps EPS8, anticorps Eps8, anticorps eps8.L, anticorps eps8

Sujet:

Background: Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression, its degradation following ubiquitination being required during G2 phase to promote cell shape changes.

Aliases: Epidermal growth factor receptor kinase substrate 8 antibody, Epidermal growth factor receptor pathway substrate 8 antibody, EPS 8 antibody, EPS8 antibody, EPS8_HUMAN antibody

UniProt: Q12929

Pathways: EGFR Signaling Pathway, Regulation of Actin Filament Polymerization